Effects of NPC16377, a potent and selective sigma receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat.
暂无分享,去创建一个
[1] W. Bowen,et al. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study , 1992, Brain Research.
[2] A. Halaris,et al. Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenics , 1985 .
[3] S J Young,et al. Self-inhibition by dopaminergic neurons , 1975, Science.
[4] S. Iversen,et al. Behavioral implications of dopaminergic neurons in the mesolimbic system. , 1977, Advances in biochemical psychopharmacology.
[5] G. F. Steinfels,et al. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[6] W. Bowen,et al. Sigma receptors: biology and function. , 1990, Pharmacological reviews.
[7] F. J. White,et al. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. , 1988, The Journal of pharmacology and experimental therapeutics.
[8] M. Pontecorvo,et al. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. , 1993, The Journal of pharmacology and experimental therapeutics.
[9] B. Bunney,et al. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. , 1984, European journal of pharmacology.
[10] S. Iversen,et al. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.
[11] C. W. Ragsdale,et al. Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat , 1988, The Journal of comparative neurology.
[12] Duncan P. Taylor,et al. Potential antipsychotic BMY 14802 selectively binds to sigma sites , 1987 .
[13] H. Wikström,et al. Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons. , 1991, European journal of pharmacology.
[14] Y. Itzhak,et al. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders. , 1990, Life sciences.
[15] A. Ceci,et al. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. , 1988, European journal of pharmacology.
[16] Stein Gf,et al. Selective σ receptor agonist and antagonist affect dopamine neuronal activity , 1989 .
[17] L. Chiodo,et al. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons , 1993, Synapse.
[18] J. Piontek,et al. Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat. , 1986, Life sciences.
[19] R. Matthews,et al. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. , 1986, The Journal of pharmacology and experimental therapeutics.
[20] A. Graybiel,et al. Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] A. Grace,et al. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. , 1979, Science.
[22] B. Bunney. The effect of antipsychotic drugs on the firing of dopaminergic neurons. A reappraisal , 1974 .
[23] Rex Y. Wang. Dopaminergic neurons in the rat ventral tegmental area. III. Effects of d-and l-amphetamine , 1981, Brain Research Reviews.
[24] R. Faull,et al. Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary glands , 1991, Brain Research.
[25] C. W. Ragsdale,et al. The fronto-striatal projection in the cat and monkey and its relationship to inhomogeneities established by acetylcholinesterase histochemistry , 1981, Brain Research.
[26] T. Su. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1982, The Journal of pharmacology and experimental therapeutics.
[27] M. Pontecorvo,et al. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile. , 1993, The Journal of pharmacology and experimental therapeutics.
[28] D. Mash,et al. Sigma receptors are associated with cortical limbic areas in the primate brain , 1992, Synapse.
[29] R. Roth,et al. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.
[30] W. Zeman. The Rat Drain. A Stereotaxic Atlas , 1964 .
[31] A. Grace,et al. Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. , 1980, Science.
[32] A. Ceci,et al. Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons , 1990, Neuroscience Letters.
[33] L. Chiodo,et al. Acute effects of Sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons , 1992, Synapse.
[34] G. Debonnel. Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. , 1993, Journal of psychiatry & neuroscience : JPN.
[35] S. Snyder,et al. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. , 1989, The Journal of neuropsychiatry and clinical neurosciences.
[36] J. Walters,et al. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion , 1980, Brain Research.
[37] M. Pontecorvo,et al. NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile. , 1993, The Journal of pharmacology and experimental therapeutics.
[38] J. Hedreen,et al. Sigma receptors in post-mortem human brains. , 1988, The Journal of pharmacology and experimental therapeutics.
[39] D. Rodbard,et al. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.
[40] S. Snyder,et al. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.
[41] H. Ujike,et al. Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization. , 1992, Life sciences.
[42] M. H. Aprison. Advances in biochemical psychopharmacology: Volume 1, edited by E. Costa and P. Greengard, Raven press (1969) , 1970 .